Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Trading Statement

14 May 2019 07:00

RNS Number : 8908Y
Ideagen PLC
14 May 2019
 

14 May 2019

 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

 

Pre-Close Trading Update

 

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management software to highly regulated industries, is pleased to provide an update on trading for the year ended 30 April 2019 ahead of the announcement of its full year results on or around 17 July 2019.

 

Trading Statement

 

The Board is pleased to report that trading for the year to 30 April 2019 has been strong and results are expected to be marginally ahead of market expectations representing the Group's tenth consecutive year of revenue and adjusted EBITDA** growth.

 

The Group expects to report revenue up 29% at approximately ÂŁ46.7million, (FY2018: ÂŁ36.1million) and adjusted EBITDA** up 30% at approximately ÂŁ14.3 million (FY2018: ÂŁ11.0 million).

 

Trading was once again robust across all key verticals with the Group delivering organic revenue growth of approximately 8 per cent* and generating a substantial increase in recurring revenues as the transition to a SaaS model continues. The Annual Recurring Revenue (ARR) book at 30 April 2019 was up 44% at approximately ÂŁ36.4 million (2018: ÂŁ25.3 million) driven by an increase in SaaS bookings coupled with the three acquisitions made within the year.

 

Cash generated by operations remained strong in the year at over 90% of adjusted EBITDA**. Net debt as at 30 April 2019 was ÂŁ1.3 million (30 April 2018: net cash of ÂŁ0.8million) having raised ÂŁ19.4m in September 2018 through a share placing and having paid a total of ÂŁ28.7 million in consideration and fees for the acquisitions of InspectionXpert, Morgan Kai, Scannell Solutions and IPI (deferred) and ÂŁ0.6 million in dividends.

 

Ben Dorks, Chief Executive commented:

 

"We are pleased to report that the Group has continued to perform well in delivering another year of quality earnings growth underpinned by strong cash generation. The Group is successfully transitioning to a SaaS business model whilst ensuring we continue to grow revenues both organically and through acquisitions. Our growing base of recurring revenues and a strong pipeline of business opportunities from new logos and our growing customer base provides the Board with confidence for the current year and beyond.

 

 

* FY2018 comparator prepared on a proforma basis as if these acquisitions had occurred during that year

**Earnings before interest, tax, depreciation, amortisation, share based payments, acquisition costs and other exceptional items.

 

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Executive Chairman

Ben Dorks, Chief Executive

Graeme Spenceley, Finance Director

finnCap Limited

020 7220 0500

Henrik Persson/James Thompson (NOMAD)

Alice Lane (ECM)

Canaccord Genuity

020 7523 8000

Simon Bridges

About Ideagen plc

Ideagen is a UK-headquartered, global technology company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

The Group provides software and services to organisations operating within highly regulated industries such as aviation, banking and finance and life science, with its main operational premises spread throughout the UK, EU, US, Middle East and SE Asia.

With an excellent portfolio of software products including Q-Pulse, Coruson, Pentana Audit and PleaseReview, Ideagen helps its clients reduce costs, improve operational efficiency, strengthen compliance and oversight and anticipate and manage every detail of risk.

Currently, more than 4,700 organisations use Ideagen's products including seven of the top 10 UK accounting firms, all of the top aerospace and defence companies and 75% of the world's leading pharmaceutical firms.

Ideagen's diverse and varied customer base includes many well-known, global brands such as British Airways, Aggreko, BAE, Ryanair, US Navy, KLM, BBVA, Bank of New York, Commerzbank, Meggitt, Heineken, Johnson Matthey, Haeco Group and European Central Bank. As well as this, Ideagen counts 180 hospitals across the UK and US amongst its client base.

For further information please visit www.ideagen.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGURUAUPBPUW
Date   Source Headline
12th Nov 20207:00 amRNSPre-Close Trading Update and Board Changes
5th Nov 202010:46 amRNSPDMR Shareholding and Exercise of Options
4th Nov 20202:30 pmRNSHolding(s) in Company
29th Oct 202011:28 amRNSHolding(s) in Company
28th Oct 20203:59 pmRNSResult of AGM
21st Oct 20202:59 pmRNSHolding(s) in Company
16th Oct 202012:44 pmRNSExercise of share options and Total Voting Rights
14th Oct 20207:00 amRNSIssue of Equity and Total Voting Rights
5th Oct 20202:19 pmRNSNotice of AGM
2nd Oct 20201:52 pmRNSHolding(s) in Company
1st Oct 20208:28 amRNSPDMR Dealing and Exercise of Options
29th Sep 20205:51 pmRNSIssue of New Shares
22nd Sep 20207:00 amRNSFinal Results
15th Sep 20203:10 pmRNSHolding(s) in Company
24th Aug 20202:36 pmRNSHolding(s) in Company
19th Aug 20203:55 pmRNSIssue of New Shares
10th Aug 20207:00 amRNSTrading Update and Acquisition of Qualsys Ltd
14th Jul 20208:44 amRNSExercise of Options and TVR
1st Jul 20207:00 amRNSBoard Changes
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:36 pmRNSPrice Monitoring Extension
22nd Jun 20207:00 amRNSExercise of Options and Total Voting Rights
16th Jun 20207:00 amRNSExercise of Options and TVR
26th May 20208:30 amRNSExercise of Options and TVR
22nd May 20207:00 amRNSPartnership with the World Health Organisation
21st May 20201:06 pmRNSHolding(s) in Company
19th May 20207:00 amRNSPre-Close Trading Update
28th Apr 20202:26 pmRNSExercise of Options and TVR
22nd Apr 20207:00 amRNSIssue of New Shares, Director Dealings and TVR
9th Apr 20207:00 amRNSExercise of Options and TVR
7th Apr 20207:00 amRNSCOVID-19 Trading Update
30th Mar 20207:00 amRNSIssue of new shares under SIP and TVR
6th Mar 20207:00 amRNSAcquisition of Workrite Ltd
25th Feb 202011:09 amRNSIssue of Equity
27th Jan 20204:56 pmRNSExercise of Options and TVR
22nd Jan 20207:00 amRNSInterim Results
20th Jan 20205:10 pmRNSIssue of Equity under Share Incentive Plan
7th Jan 20207:00 amRNSBoard Change
17th Dec 20194:08 pmRNSIssue of Equity
13th Dec 20194:38 pmRNSDirector/PDMR Shareholding
3rd Dec 20192:44 pmRNSHolding(s) in Company
2nd Dec 201911:29 amRNSPDMR Dealing and Total Voting Rights
29th Nov 20199:57 amRNSHolding(s) in Company
21st Nov 20194:06 pmRNSHolding(s) in Company
20th Nov 201911:58 amRNSDirector/PDMR Dealings and Total Voting Rights
18th Nov 20192:00 pmRNSIssue of Shares under Share Incentive Plan
13th Nov 20197:00 amRNSTrading Update
30th Oct 20193:48 pmRNSResult of AGM
24th Oct 20197:00 amRNSBoard Change
23rd Oct 201911:45 amRNSShare Incentive Plan and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.